Lack or downregulation of the dopamine D2 receptor (D2R) increases the vulnerability to renal inflammation independently of blood pressure in mice. Common single nucleotide polymorphisms (SNPs) rs 6276, 6277 and 1800497 in the human D2R gene are associated with decreased receptor expression/function, and hypertension. Human renal proximal tubule cells from subjects carrying these SNPs have decreased D2R expression and increased expression of pro-fibrotic factors and production of extracellular matrix proteins. We tested the hypothesis that the D2R mediates these effects by regulating microRNA expression. In cells carrying D2R SNPs, microRNAs (miRs)-217, -224, -335 and -1265 were downregulated while miR-1290 was upregulated more than 4-fold compared with those carrying D2R wild-type (WT) alleles. However, only miR-217 was directly regulated by D2R expression. In cells carrying D2R WT, miR-217 inhibitor increased the expression of TGFβ1, MMP3, FN1, and Col1a while miR-217 mimic had the opposite effect. In cells carrying D2R SNPs, miR-217 mimic also decreased the expression of TGFβ1 and its targets. Wnt5a, a miR-217 target, was increased in cells carrying D2R SNPs, and decreased by miR-217 mimic but increased by miR-217 inhibitor in both cell types. In cells carrying D2R WT, Wnt5a treatment increased TGFβ1 while silencing Ror2, a Wnt5a receptor, decreased TGFβ1 and blunted the Wnt5a-induced increase in cells carrying D2R WT. Our results show that renal proximal tubule cells from subjects carrying D2R SNPs resulting in D2R downregulation have increased TGFβ1 that is mediated by decreased regulation of the miR-217-Wnt5a-Ror2 pathway.